Our website

Who is this website for?

Our website provides a variety of information for any person wanting to know more about viral hepatitis. This includes people impacted by viral hepatitis and the workforce that engages with and supports them. The site includes information about hepatitis A, B and C as well as information about projects, services, news and research associated with these conditions.

Hepatitis Australia does not provide direct services to individuals but provides information to assist people in accessing support. To locate the nearest hepatitis organisation please refer to our local hepatitis organisations page

Funding for this website.

The Hepatitis Australia website is made possible through grants from the Australian Government Department of Health. From time to time, some content on this site may be supported by other sources of funding. Where this is the case it will be stated within that material.

Advertising on this website.

The Hepatitis Australia website does not host any form of commercial advertising or promote specific commercial products. From time-to-time the website will include the promotion of non-commercial opportunities or services relevant to people impacted by viral hepatitis or people working in the area of viral hepatitis.

Website administration.

This website is maintained by the Communications Team at Hepatitis Australia, managed by Kevin Marriott, Director of Program and Communications Manager. You can contact the Communications Team via email

Editorial committee

All information on this site has been through a review process, including clinical reviews of medical information.

Since March 2020, all new resources are reviewed by the Hepatitis Australia Editorial Committee, unless otherwise stated. The committee provide advice on accuracy and accessibility of documents. They collectively offer expertise on clinical information, epidemiology, lived experiences and communications.

The current members of the Hepatitis Australia Editorial Committee are:

Dr Alice Lam
Digby Hildreth
Jane Little
Jennifer MacLachlan
Prof Narci Teoh
Sidney Vo

Page updated: 3 March 2020

Latest

Parliamentary Morning Tea: We can eliminate hepatitis C!

The Parliamentary Friends Group for Action of Blood Borne Viruses Co-Chairs, Tim Wilson, MP and Senator Louise Pratt invite you to a Parliamentary Morning Tea on Thursday 12 November.
Renewed calls for Needle & Syringe Programs in prisons ahead of International Drug Users Day

The Australian Injecting and Illicit Drug Users League (AIVL) and Hepatitis Australia are highlighting international calls for Needle and Syringe Programs (NSPs) in prisons, along with a greater focus on harm reduction initiatives, ahead of International Drug Users Day on 1 November.
Investment in hepatitis research needs to be accompanied by National Strategy implementation funding

6 October 2020 - Hepatitis Australia welcomes the Australian Government’s commitment to diverse hepatitis research, however we remain concerned that the 2019 Health Budget funding for hepatitis commitments is yet to hit the ground.
Investment in liver cancer medicines matched with prevention are changing Australian lives

6 October 2020 - Hepatitis Australia welcomes the Australian Government’s significant investment of $230 million to expand the listing of Tecentriq® and Avastin® (atezolizumab and bevacizumab) on the Pharmaceutical Benefits Scheme (PBS).